RAM Group, a Singapore based multi-national Technology Startup Company, announced its Quantum Cardio-Respiratory Monitor (qCRM™), the first-of-its-kind integrated single-point, non-invasive, bio-electro-mechanical sensor with the potential to provide full-body diagnostics and analysis.
In a feasibility study, the company conducted in collaboration with the Giessen University Hospital in Germany, the non-invasive device outperformed other more traditional measures. The technology holds great promise for SPM sensors that can be utilized at point-of-care or through wearable devices. RAM Group is now seeking additional funding for further research and validation, said a press release.
“In our study, the qCRM performed extremely well against the litany of accepted monitoring technologies. This is remarkable noting that the qCRM utilizes only one point of contact to receive data from the patient,” said Dr. Ardeshir Ghofrani, 2015 German Future Prize winner and leader of the research team at Giessen University Hospital. “To be able to receive this level of organ function detail from a single point sensor is extremely exciting. The potential uses for this diagnostic and monitoring technology are significant.”
The qCRM sensor integrates multi-parametric (Heart rate, Right Atrial Pressure, Left Atrial Pressure, Central Venous Pressure, Breathing rate) and multi variant (Heart Rate Variability, Blood Pressure, Cardiac-Output, Circulatory Dynamics, Field-Propagation Dynamics) signals into unified waveforms, representing the comprehensive bodily functions and processes. The greater insights and data-sets generated in any applications using the qCRM platform have great opportunities for integration with existing risk stratification algorithms and deciphering hidden risk factors for cardio-pulmonary conditions and beyond.
Existing technologies monitor a single-field or effect, like the photoplethysmography (PPG) sensor found in all wearable smartwatches today. The PPG sensor is limited to a single waveform measuring changes in light absorption representing the perfusion of blood to the dermis and subcutaneous tissue of the skin.
Utilizing RAM Group’s proprietary qDS technology, the sensor merely needs to touch a single point on the body to begin analyzing the REAL or DIRECT pressure(s) related to cardio-pulmonary function.
Ayal Ram, Founder and CEO, the RAM Group said they are thrilled that after almost ten years of research and hard work, they’re on the verge of making single-point monitoring and analysis a reality. “Our dream of changing how illnesses are diagnosed is made possible through our quantum device sensing technology. Our research shows that we’re on the right track. These sensors are capable of reshaping medical science as we know it, with the potential to aid immediate and hyper-accurate diagnosis of illness or disorder in the heart, lungs and other organs,” he said.